| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 7.728 | 30.596 | 30.078 | 35.189 | 46.255 | 46.689 | 59.888 | 60.073 | 93.526 | 103.375 |
| Total Income - EUR | 7.728 | 30.596 | 30.078 | 35.189 | 46.255 | 46.689 | 59.888 | 60.073 | 98.580 | 103.375 |
| Total Expenses - EUR | 4.201 | 18.568 | 13.075 | 14.766 | 19.351 | 19.095 | 20.067 | 23.182 | 21.311 | 30.475 |
| Gross Profit/Loss - EUR | 3.526 | 12.028 | 17.003 | 20.422 | 26.905 | 27.594 | 39.820 | 36.892 | 77.268 | 72.900 |
| Net Profit/Loss - EUR | 3.294 | 11.110 | 16.702 | 20.070 | 26.442 | 27.162 | 39.233 | 36.303 | 76.302 | 70.970 |
| Employees | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
Check the financial reports for the company - Pharmacliniq Resource Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 171 | 108 | 46 | 20.099 | 13.886 | 9.813 | 3.949 | 451 | 0 | 0 |
| Current Assets | 3.400 | 11.835 | 23.852 | 30.213 | 31.540 | 28.351 | 40.652 | 39.143 | 85.934 | 83.890 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 0 | 0 | 2.507 | 1.751 | 2.107 | 1.861 | 8.288 | 25.794 | 61.446 | 23.642 |
| Cash | 3.400 | 11.835 | 21.346 | 28.461 | 29.433 | 26.491 | 32.364 | 13.348 | 24.489 | 60.248 |
| Shareholders Funds | 3.339 | 11.163 | 23.299 | 20.122 | 26.493 | 27.212 | 39.282 | 36.351 | 76.351 | 71.019 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 232 | 780 | 599 | 30.189 | 18.934 | 10.953 | 5.319 | 3.243 | 9.584 | 12.872 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8299 - 8299" | |||||||||
| CAEN Financial Year |
8299
|
|||||||||
Comments - Pharmacliniq Resource Srl